Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5.07M
-
Number of holders
-
482
-
Total 13F shares, excl. options
-
19.1M
-
Shares change
-
+74.2K
-
Total reported value, excl. options
-
$9.43B
-
Value change
-
+$17.4M
-
Put/Call ratio
-
2.9
-
Number of buys
-
211
-
Number of sells
-
-262
-
Price
-
$495.00
Significant Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q2 2022
572 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock as of Q2 2022.
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) has 482 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.1M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (2.35M shares), BlackRock Inc. (1.59M shares), STATE STREET CORP (956K shares), Veritas Asset Management LLP (767K shares), FMR LLC (703K shares), ALLIANCEBERNSTEIN L.P. (616K shares), BROWN ADVISORY INC (582K shares), GEODE CAPITAL MANAGEMENT, LLC (440K shares), BANK OF AMERICA CORP /DE/ (408K shares), and ACADIAN ASSET MANAGEMENT LLC (403K shares).
This table shows the top 482 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.